IDYA
IDEAYA Biosciences, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
IDEAYA Biosciences (IDYA) Stock: Buy, Sell, or Hold?
$32.40
+0.65 (+2.05%)
▲
5d:
+0.12%
30d:
-5.43%
90d:
-11.67%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$32.44 – $37.00
Position: OVERSOLD
Forward P/E & Valuation
-7.7x
Next 12M consensus est.
Wall Street Target
$51.08
+60.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$30.45 / $34.51
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: IDYA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When IDYA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IDYA is currently trading at $32.40, which is considered oversold relative to its 30-day fair value range of $32.44 to $37.00.
Technical Outlook: Technically, IDYA is in a downtrend. Immediate support is located at $30.45, while resistance sits at $34.51.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $51.08 (+60.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IDYA is in a downtrend. Immediate support is located at $30.45, while resistance sits at $34.51.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $51.08 (+60.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$32.44 -
$37.00
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$32.44 -
$37.00
Current vs Trading Range
OVERSOLD
Support Level
$30.45
Resistance Level
$34.51
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 60.9% below Wall St target ($51.08)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-7.66
Wall Street Target
$51.08
(+60.9%)
Revenue Growth (YoY)
-95.1%
Share IDYA Analysis
Share this live IDYA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IDYA)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 19, 2026
Daily AI digest
AI Retail Discussion Summary:
IDEAYA Biosciences announced promising clinical data for their drug darovasertib in the treatment of metastatic and primary uveal melanoma at ESMO 2026, with data supporting its potential to become a foundational new therapy.
Key Retail Themes:
clinical trial data
potential new therapy for uveal melanoma
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 12:49 PM ET
Data refreshes hourly during market hours. Next update: 1:49 PM
Data refreshes hourly during market hours. Next update: 1:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IDYA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
RZLT
Rezolute Inc |
STRONG BUY
11 analysts |
$10 | 72 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IDYA Research Pages
